Within the study population, approximately 49% of patients were lost to follow-up or did not complete adjuvant treatment through 5 years. Fifty-two percent of patients switched to a different ...
IT HAS BEEN 12 YEARS since Congress ordered the Environmental Protection Agency to develop the Endocrine Disruptor Screening Program (EDSP) to test pesticides and other chemicals for their ability to ...
Immune checkpoint inhibitors (ICPis) have proven extremely efficacious in cancer therapy but also lead to a plethora of immune-related adverse events (irAEs). The endocrine irAEs are not only quite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results